Skip to main content
Premium Trial:

Request an Annual Quote

'Post-Election Panic'

A US House of Representatives budget subcommittee has recommended that the US National Institutes of Health receive no budget increase in 2013. Any other year, this would be bad news but this year, some researchers may be heaving sighs of relief that the news wasn't worse, say Ivan Semeniuk and Helen Thompson at Nature News — at least, so far. With the presidential elections coming up in November, many funding agencies are already expecting a "post-election panic," Semeniuk and Thompson write — the major reason being an upcoming pre-programmed budget cut, called a sequester, that could effectively "starve US science-funding agencies." Congress is too divided to come to an agreement before the sequester is automatically implemented in less than six months. "And even if Congress does manage to introduce last-minute legislation, as many observers expect, the sequester will have cast a shadow over the contentious process of funding science in a time of fiscal constraints — and in an election year," Semeniuk and Thompson add.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.